Dynamic Rare Disease Specialist at Pfizer with established expertise in molecular diagnostics and strategic decision-making. Delivered exceptional territory growth while cultivating robust partnerships with key healthcare decision-makers. Acknowledged for surpassing performance objectives and implementing impactful business strategies in rare disease markets.